Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH’s Robert Gallo

Executive Summary

Formal investigation "is warranted" of Gallo's National Cancer Institute Laboratory, National Institutes of Health Acting Director William Raub announced Oct. 5. The investigation will focus on several aspects of published reports from Gallo's lab, particularly the article by Mika Popovic, et al., published in the May 1984 issue of Science, that first described HIV. The investigation will also conduct tests to determine the origins of the HTLV-IIIB virus that Gallo and his colleagues used to develop the blood test for HIV. Raub noted that the initial inquiry into Gallo's research by NIH's Office of Scientific Integrity "has resolved certain of the publicized allegations and issues or shown them to be without substance. In particular, the inquiry team has concluded that Dr. Gallo had a substantial number of HIV detections and isolations from several different sources at the critical time that HTLV-IIIB (the principal virus isolated by the Gallo laboratory) and LAV (the virus isolated by the Pasteur Institute) were being grown in Gallo's laboratory".

Latest Headlines
See All
UsernamePublicRestriction

Register

PS018179

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel